Keyphrases
Advanced Hepatocellular Carcinoma
13%
Atezolizumab
7%
Bevacizumab
7%
BRAF Inhibitor (BRAFi)
12%
Cancer Cells
21%
Cancer Metastasis
11%
Catenin
16%
Cellular Senescence
18%
CpG Island Methylation
35%
Epigenetic Mechanisms
11%
Epigenetic Modification
7%
Epigenetics
27%
Erlotinib
8%
Gene Expression
7%
Genetic Modification
11%
Hepatocellular Carcinoma
100%
Hepatocytes
18%
Histone Modification
12%
Human Cancer
45%
Immune Checkpoint Inhibitors
11%
Immune Evasion
12%
In Cancer
27%
Inhibitor Activity
9%
Insulin-like Growth Factor 2 (IGF2)
9%
Liver
13%
Liver Cancer
35%
Liver Regeneration
9%
Metastasis
9%
MicroRNA
42%
Mouse Model
13%
Multikinase Inhibitor
8%
Non-cell Autonomous
15%
Non-coding RNA (ncRNA)
13%
Oncogene
9%
Prostate Cancer
21%
Senescence
18%
Senescence-associated Secretory Phenotype
10%
Senescent Cells
8%
Therapeutic Implications
14%
Transforming Growth Factor-β
9%
Tumor
37%
Tumor Cells
10%
Tumor Growth
11%
Tumor Heterogeneity
9%
Tumor Microenvironment
8%
Tumor Progression
7%
Tumor Suppressor
9%
Tumor Suppressor Gene
10%
Tumor Suppressor miRNA
13%
Ultraconserved Region
9%
Biochemistry, Genetics and Molecular Biology
Biological Phenomena and Functions Concerning the Entire Organism
5%
Cadherin
6%
Cancer Cell
37%
Cancer Growth Factor
9%
Carcinogenesis
5%
Catenin
18%
Cell Cycle Arrest
8%
Cell Cycle Checkpoint
8%
Cell Death
6%
Chemokine
5%
CpG Island
30%
DNA Methylation
17%
Enzyme
5%
Epidermal Growth Factor Receptor
9%
Epigenetics
30%
Epigenetics
8%
Epigenomics
8%
Evolution
5%
Gene Expression
7%
Gene Expression Profiling
6%
Gene Mutation
8%
Genetically Engineered Mouse Strain
6%
Genetics
17%
Genomics
9%
Hepatocyte
15%
Histone Modification
7%
Homeostasis
5%
Immune Checkpoints
7%
Immune Evasion
8%
Immunity
39%
Immunocompetent Cell
7%
Kinase
14%
KRAS
9%
Liver Regeneration
9%
MicroRNA
38%
Mouse Model
22%
Myeloid
11%
Non-Coding RNA
6%
Oncogene
12%
Ontogeny
9%
Phosphotransferase
14%
Promoter Region
7%
RNA-binding Protein
7%
Stem Cell
5%
T Cell
12%
Transcription Factors
8%
Transcriptomics
12%
Tumor Progression
17%
Tumor Suppressor Gene
7%
Tumor Suppressor Protein
26%
Medicine and Dentistry
Cadherin
5%
Cancer Cell
9%
Cancer Inhibition
5%
Carcinogenesis
8%
Cellular Senescence
11%
Cholangiocarcinoma
7%
Disease
14%
DNA Methylation
6%
Epigenetic Mechanism
6%
Erlotinib
8%
Fibrosis
6%
Gene Expression
5%
Hepatic Stellate Cell
5%
Hepatocellular Carcinoma
57%
Hepatocyte
7%
Immunity
17%
Immunotherapy
18%
Leukemia
5%
Liver Cancer
20%
Liver Disease
9%
Lung Tumor
6%
Malignant Neoplasm
41%
Metastatic Carcinoma
9%
microRNA
9%
Neoplasm
41%
Oncogene
6%
Ontogeny
9%
Personalized Medicine
6%
Phosphotransferase
6%
Phosphotransferase Inhibitor
6%
Primary Tumor
6%
Programmed Cell Death
7%
Prostate Cancer
8%
Sorafenib
5%
T Cell
8%
Targeted Therapy
5%
Tumor Progression
9%
Tumor Suppressor Protein
7%
